je.st
news
Gilead Sciences, Inc. (GILD) Downgraded by Vetr Inc. to "Buy"
2016-04-04 08:36:27| Biotech - Topix.net
They presently have a $104.96 target price on the biopharmaceutical company's stock. Vetr 's target price would suggest a potential upside of 11.52% from the stock's current price.
Tags: to
buy
sciences
downgraded
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|